Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Has results × folfirinox × Clear all

Phase

Phase 2 8 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Cyclophosphamide 119 pembrolizumab 98 Carboplatin 83 Nivolumab 81 Paclitaxel 76 Rituximab 72 Gemcitabine 68 Dexamethasone 67 Radiotherapy 60 Lenalidomide 58 Cytarabine 57 Cisplatin 55 Etoposide 52 Bevacizumab 52 fludarabine phosphate 49 Docetaxel 47 fludarabine 45 Bortezomib 43 Temozolomide 41 Erlotinib Hydrochloride 40 Doxorubicin 39 Prednisone 38 Capecitabine 38 Everolimus 37 Vorinostat 36 Sorafenib 36 Ipilimumab 36 Azacitidine 36 Melphalan 35 Filgrastim 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03828799 2026-02-27

FOLFIRINOX-R

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 1/2 Completed

13 enrolled 22 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡